Today’s top gainers include the company AstraZeneca PLC (NYSE:AZN) which is in the industry Drug Manufacturers – Major, gaining -0.57% today. In the last week its performance is -3.27%, and 9.46% for the past quarter. Currently, AstraZeneca PLC, AZN has a target price of 36.09, so today’s gain of -0.57% is a significant step towards its target price. The GAP today is therefore -0.42%.
AstraZeneca PLC (NYSE:AZN), has a market cap of 82759.23, and is based in United Kingdom. Insider ownership is at 0.50%, and institutional ownership is 12.20%.
At the current price of 32.86, it has a dividend yield of 2.74%, and its target price is 36.09. This is with a profit margin of 9.20%, and total debt/equity of 1.3. AstraZeneca PLC (NYSE:AZN) has a P/E of 37.43, as well as a forward P/E of 12.31.
With a current EPS of 0.88, and a forecasted EPS growth for next year at -10.10%,AstraZeneca PLC (NYSE:AZN) has had a EPS growth for the past five years at -16.70%. For the next five years EPS growth is projected to be -1.00%.
Performance for the year is 8.14%. Since its IPO date on 5/17/1993, the total performance to date is 1.26%.
Volume today for AstraZeneca PLC (NYSE:AZN), is 4451200, while its average volume is 5981.76. Whilst the total gain today was -0.57%, it did have a day high of -4.97%.
Volatility for this week has been at 1.39%, and 1.37% for the month. The 52-week low for AstraZeneca PLC, AZN has been 23.47%, while the 52-week-high has reached -4.97%.
Looking at its return of investments, which is 11.50%, and its return on assets is 3.70%. AstraZeneca PLC (NYSE:AZN) has an operating margin of 15.00%. With a sales growth of -11.20% quarter over quarter. Bearing in mind that AstraZeneca PLC, AZN is in the sector Healthcare, its long-term debt/equity is 1.22, and has a current ratio of 0.9 and 0.8 for quick ratio.
So what is the value of AstraZeneca PLC? Well its PEG is *TBA, and the P/S is 3.44, along with a P/B of 6.14. Meanwhile it has a p/cash of 17.81.